Comparison of ranitidine and lansoprazole in short‐term low‐dose triple therapy for <i>Helicobacter pylori</i> infection

Abstract

No significant differences in cure rate and safety profiles were noted between the two regimens, suggesting that moderate acid inhibition using an H2-blocker is sufficient to achieve optimal H. pylori eradication.